Table 1.
Baseline characteristics of 39 patients.
| Characteristic | Value (median (IQRs) or no. (%)) |
|---|---|
| Age (years) | |
| Years | 56 (34, 66) |
| Distribution | |
| ≤18 years old | 4 (10.3%) |
| 19–40 years old | 6 (15.3%) |
| 41–60 years old | 12 (30.8%) |
| >60 years old | 17 (43.6%) |
| Male sex | 30 (76.9%) |
| Onset symptoms | |
| Dyspnea | 21 (53.8%) |
| Fever | 26 (66.7%) |
| Cough | 30 (76.9%) |
| Hemoptysis | 3 (7.7%) |
| Inflammation biomarker | |
| WBC (109/L) | 10.5 (8.5, 14.8) |
| NEU (%) | 85.8 (77.7, 90.3) |
| Lym (109/L) | 0.78 (0.59, 1.47) |
| PCT (ng/ml) | 0.81 (0.17, 2.3) |
| CRP (mg/L) | 122 (34, 187) |
| ESR (mm/h) | 57 (29, 84) |
| Comorbidity | |
| Diabetes mellitus | 7 (17.9%) |
| Chronic kidney disease | 9 (23.1%) |
| Liver disease | 4 (10.3%) |
| Immunocompromised | |
| Solid organ transplantation | 2 (5.1%) |
| Malignancies | 1 (2.6%) |
| Chemotherapy | 3 (7.7%) |
| Immunosuppression for rheumatological diseases | 4 (10.3%) |
| Immunosuppression for chronic kidney disease | 4 (10.3%) |
| ICU admission | 35 (89.7%) |
| Severity score | |
| APACHE II | 14.0 (7.8, 21.5) |
| SOFA | 4.5 (2.0, 9.0) |
| Disease-onset to sampling time (days) | 22 (12, 36) |
| Length of stay (days) | |
| In hospital | 16 (8, 39) |
| In ICU | 12 (4, 30) |
Abbreviations: WBC, white blood cells; NEU%, percentage of neutrophil; Lym, lymphocytes; PCT, procalcitonin; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; APACHE, acute physiology and chronic health evaluation scoring system; SOFA, sequential organ failure assessment; ICU, intensive care unit.